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Summary 
Each year in Australia approximately 551 children are born with moderate to profound 
permanent childhood hearing impairment (PCHI) (MSAC 2007). Universal neonatal hearing 
screening aims to identify those children born with moderate to profound PCHI and provide 
them and their families with access to an appropriate intervention in order to minimise the 
impact of their hearing impairment. Universal neonatal hearing screening is undertaken in 
each Australian state and territory.  
This working paper presents a set of performance indicators for monitoring neonatal hearing 
screening activity in Australia at a national level. National evaluation and monitoring 
provides a measure of how well neonatal hearing screening is achieving its aims and 
objectives and will enable strengthening of screening practices and administrative processes 
to further improve outcomes for Australian infants.  
The indicators are based on the aims, standards and objectives for neonatal hearing 
screening outlined in the National Framework for Neonatal Hearing Screening (NHSWG 2013). 
They were developed in consultation with experts and endorsed by the Community Care 
and Population Health Principal Committee.  
This working paper documents both the indicator development process and the technical 
specifications for the indicators. This working paper also identifies potential data sources, 
data elements and future data development and evaluation needs. 
Key findings 
Seven national performance indicators are described that cover four key areas along the 
screening pathway. The indicators, and how each relates to the four key aims of neonatal 
hearing screening, are listed below.  
Table S.1: National performance indicators for neonatal hearing screening in Australia 
Performance indicators Aim 
Indicator 1 Participation  To maximise the number of eligible infants screened for 
permanent childhood hearing impairment 
 1.1 Participation in screening 
Indicator 2 Screening To maximise the identification of infants with potential hearing 
impairment while minimising parental anxiety and cost 
 2.1 Positivity rate of the screening test  
 2.2 Positive predictive value of the screening test 
Indicator 3 Audiological assessment and diagnosis To accurately identify infants born with permanent childhood 
hearing impairment 
 
 3.1 Audiological assessment 
 3.2 Detection of permanent childhood hearing 
 impairment  
Indicator 4 Early intervention and management To maximise engagement of infants identified as requiring a 
service with early intervention services 
 4.1 Attend early intervention service 
 4.2 Infants fitted with an assistive hearing device 
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1 Introduction 
1.1 Purpose and structure 
This working paper should be considered in the context of the National Framework for 
Neonatal Hearing Screening. It aims to provide the Australian neonatal hearing community 
with a national reference point for monitoring of neonatal hearing screening activity and 
outlines the development of seven performance indicators. It also provides technical 
specifications and lists data elements necessary to calculate and report against these 
indicators. 
This working paper has four chapters: 
• Chapter 1 details the historical background and governance of national monitoring of 
neonatal hearing screening in Australia and highlights key issues that require further 
consideration before implementing standardised reporting for neonatal hearing 
screening in Australia. 
• Chapter 2 provides basic information on performance indicators and the data and 
metadata that are an essential part of using indicators to measure performance. The 
second half of the chapter describes the indicator development process and presents the 
national performance indicator set. 
• Chapter 3 details the national performance indicators in the order an infant progresses 
through the screening pathway. Each indicator is presented with accompanying 
explanatory information including a definition that explains what the indicator is 
measuring and a brief rationale for inclusion.  
• Chapter 4 presents clear and concise technical information including a numerator and 
denominator for calculating each indicator to ensure all those who collect, provide, 
analyse and use the data clearly understand its meaning.  
 
1.2 Childhood hearing impairment in Australia 
Each year in Australia approximately 551 children are born with moderate to profound 
permanent childhood hearing impairment (PCHI) (MSAC 2007). Early detection of PCHI, 
coupled with access to an appropriate intervention, minimises the impact of hearing 
impairment for children born with PCHI by potentially improving their communication and 
language skills, subsequent education and employment prospects, and psychological 
wellbeing (Yoshinaga-Itano 2003; Moeller 2000).  
1.3 Background and governance 
Evidence to recommend the screening of newborns for hearing impairment was determined 
by the National Health and Medical Research Council in 2002 and supported by the Medical 
Service Advisory Committee in 2008.  
In March 2008, the Screening Subcommittee of the Australian Population Health 
Development Principal Committee (APHDPC) of the Australian Health Ministers Advisory 
Council established the Neonatal Hearing Screening Working Group (NHSWG) to provide 
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high level advice on how to progress issues related to universal neonatal hearing screening 
in Australia. 
In September 2009, a Senate Inquiry into hearing health in Australia was established to 
report on the extent, causes and costs of all hearing impairment in Australia. The report, 
titled Hear us (The Senate Community Affairs References Committee 2010), was tabled in 
May 2010. The Committee supported the development of a national register for neonatal 
hearing screening and recommended that it be able to:  
• track children through neonatal hearing screening, diagnosis and intervention 
• record and report cognitive, linguistic, social and emotional development outcomes of 
children diagnosed at birth with a hearing loss 
• be expanded in future years to track all children diagnosed with a hearing impairment 
later in life. 
1.3.1 Data development activities for neonatal hearing screening 
The NHSWG was tasked with developing a screening pathway for neonatal hearing 
screening; developing minimum national standards for screening and post screening 
services; and establishing a national quality and reporting framework to underpin a national 
approach to data collection. NHSWG undertook the work in two stages.  
The first stage involved the development of the National Guidelines for Neonatal Hearing 
Screening: Draft National Framework (later titled the National Framework for Neonatal Hearing 
Screening, NHSWG 2013). The framework defines the screening pathway for neonatal 
hearing screening and outlines minimum national standards to underpin reporting for 
neonatal hearing screening in Australia and provide quality service delivery. At the 
APHDPC meeting on 9 March 2011, members endorsed the Framework pending a review of 
the proposed performance indicators to enable nationally consistent reporting.  
The second stage involved the development of a reporting framework for consideration by 
the Screening Subcommittee, and to establish an agreed approach to data collection, 
management and sharing.  
To progress this work, the Australian Institute of Health and Welfare (AIHW) conducted an 
analysis of available national data sources relating to neonatal hearing screening and 
presented a discussion paper Data requirements to support a national approach to neonatal hearing 
screening (AIHW unpublished) to the NHSWG for consideration at their March 2010 meeting. 
This discussion paper reviewed existing data collections relating to infants and young 
children in Australia, presented potential models for collecting data and monitoring neonatal 
hearing screening, and made a number of recommendations including the development of a 
nationally consistent set of data elements. 
In response to these recommendations, the NHSWG convened a working subgroup, the 
Neonatal Data Specification Subgroup (NDSS), chaired by the AIHW to oversee and 
coordinate the development of a core set of performance indicators and associated technical 
specifications and data elements for national reporting and analysis of neonatal hearing 
screening in Australia. A draft of these performance indicators was presented to the 
Screening Subcommittee in March 2011.  
Responsibility for implementation of the framework was passed from the Screening 
Subcommittee to the Child Health and Wellbeing Subcommittee (now Standing Committee 
on Child and Youth Health – SCCYH), a subcommittee of the Community Care & Population 
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Health Principal Committee (CCPHPC) in November 2011. The framework was revised by 
the SCCYH and the title was changed to the National Framework for Neonatal Hearing Screening 
(NHSWG 2013). The revised framework and the associated performance indicators 
presented here were endorsed by the CCPHPC in August 2013. 
The national framework recognises that neonatal hearing screening has developed separately 
across jurisdictions with various levels of sophistication. It was developed in consultation 
with jurisdictions with an aim of achieving harmonisation of these efforts.  
The national framework and performance indicators presented in this working paper are 
intended as a resource for jurisdictions to use when developing and monitoring neonatal 
hearing screening services. 
1.4 Aims and objectives of neonatal hearing 
screening 
The aim of neonatal hearing screening is for all infants to be screened for congenital PCHI, 
and, if necessary, to have access to appropriate intervention to minimise the impact of their 
hearing impairment. This will improve the quality of life for children with PCHI in terms of 
their communication and language skills, subsequent education and employment prospects, 
and psychological wellbeing. 
The objectives of neonatal hearing screening are to: 
• maximise the early detection of congenital PCHI in Australian infants through the use of 
an approved screening test and appropriate follow up medical and support services 
• ensure that all Australian families are offered the opportunity to participate in neonatal 
hearing screening 
• ensure equitable access to neonatal hearing screening for all Australian infants 
irrespective of their geographic, socioeconomic or cultural background 
• ensure that assessment services provided to infants requiring follow up care and 
intervention as a result of screening are timely, acceptable and appropriate and are 
undertaken in accordance with professional standards 
• ensure families with infants diagnosed with impaired hearing engage with an early 
intervention service following diagnosis  
• maximise benefit and minimise harm to the individual 
• achieve consistent standards of screening management, co-ordination, quality and 
safety, service delivery, monitoring, evaluation and accountability 
• ensure that the national approach to neonatal hearing screening is implemented in a 
manner that is cost effective and will significantly increase quality of life for Australian 
children with PCHI. 
1.5 Issues for consideration 
This section details issues that may need to be considered in using these indicators. Further 
issues specific to each indicator are detailed in chapters 3 and 4. 
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1.5.1 Definitions and terminology 
Fundamental to the development of national reporting for neonatal hearing screening is 
clarity on definitions and terms.  
1.5.1.1 Undefined and non-standard terms 
A glossary of standard terms is included at the end of this working paper; however, there are 
a number of terms such as ‘eligible’, ‘medically unfit’ and the ‘corrected age’ of infants that 
will require consensus for nationally consistent monitoring.  
Some suggestions and examples are provided in the discussion for the indicators. 
1.5.1.2 Describing screening outcomes 
Clinicians involved in neonatal hearing screening use the terms pass and refer to classify 
outcomes from the screening test. To facilitate clear communication between screeners, 
nurses, doctors, audiologists, data managers and infant hearing screening program 
managers; it is recommended that when discussing the monitoring and evaluation of 
neonatal hearing screening the terms pass and refer are changed to: 
• negative screening result which indicates that the screening test was negative for 
suspected hearing loss (pass) 
• positive screening result which indicates that the screening test was positive for 
suspected hearing loss (refer). 
This terminology is consistent with both the World Health Organization principles of early 
disease detection (Wilson 1968) and the Australian Population Health Development 
Principal Committee Screening Subcommittee (APHDPCSS) Population Based Screening 
Framework (APHDPCSS 2008) and is used in these indicators to describe outcomes of the 
screening test. 
1.5.2 The target population 
In order for indicators to successfully monitor the impact of screening, they must refer to a 
clearly defined target population, which is referred to as the ‘eligible’ population. These 
indicators are developed based on the following considerations. 
1.5.2.1 Inclusion of infants with symptoms or a risk factor  
Theoretically, screening involves the testing of an asymptomatic population (that is, 
individuals who have no symptoms or signs of the condition). In practice however, screening 
programs routinely include individuals who are symptomatic or at increased risk of 
suffering from an illness. This occurs not only because it is in the interest of the community 
to ensure those at higher risk or with symptoms receive access to medical services, but also 
because identification of these individuals is often difficult at population level. 
An estimated 40% to 60% of children diagnosed with congenital PCHI display a known risk 
factor (Bailey et al. 2002). These infants form part of the target population for the indicators 
presented here. 
1.5.2.2 Infants not eligible for screening  
While the aim of neonatal hearing screening is for all infants to be screened for congenital 
PCHI by 4 weeks of (corrected) age, this is restricted to eligible infants. Infants who are not 
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eligible for screening include infants deemed to be medically unfit for screening. It is 
anticipated that this subgroup of infants will be very small and best monitored at the 
jurisdictional level. Note that the term ‘medically unfit’ is not defined and may differ 
between jurisdictions. Box 1 presents protocols used by Queensland Health for infants 
considered medically unfit for screening. 
Box 1: Queensland Health protocols for infants considered medically unfit for 
screening 
In rare situations, screening may not be possible or is medically inadvisable. The decision to 
exclude a baby from the screening program must be made by the treating clinician. Such 
situations include: 
• when it is medically inadvisable to attach the sensors and/or ear couplers: for 
example, if the baby has compromised skin 
• the presence of a major cranio-facial abnormality: in particular the absence of outer ear 
anatomy, including babies with unilateral or bilateral atresia 
• for babies with only 1 normal-looking ear, do not screen the ‘good’ ear 
• other conditions which medical staff deem require a full diagnostic assessment by 
audiology. 
1.5.2.3 Measuring how many families decline screening 
Families have the right to decline screening services. Although it is anticipated that only a 
small proportion of families will do so, it is important to monitor the proportion of families 
who decline screening. A high decline rate, especially if it is higher for some population 
subgroups compared to others, could warrant implementation of programs to address this 
issue as higher participation at each point along the screening pathway is necessary for 
achieving the best outcomes for infants.  
It is considered that monitoring the decline rate is a program management issue and should 
not form part of a performance indicator set at the national level. 
1.5.3 Data considerations  
In order to report against these indicators, the following issues should be considered when 
developing data collections to support the monitoring and evaluation of neonatal hearing 
screening.  
1.5.3.1 National v. jurisdictional data collection 
These indicators were originally developed to be reported against using a national data 
collection; however, the indicators are also suitable to be used and reported by state and 
territory neonatal hearing screening programs.  
1.5.3.2 Data availability 
Good quality, reliable, appropriate data are central to indicator-based monitoring. To be 
useful, the data need to be provided from a reliable source and available on a regular basis. 
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1.5.3.3 The use of identified data and a data linkage key 
Many of the aims and objectives of neonatal hearing screening are long term and not easily 
measurable, in particular the improvement of social, emotional and educational outcomes for 
infants born with PCHI. It is recommended that identified data and/or a data linkage key be 
developed to enable future linkage with a number of medical, educational and employment 
administrative datasets in order to assess whether neonatal hearing screening in Australia is 
meeting these long term aims.  
Data linkage can only be done after approval from appropriate Ethics Committees in 
accordance with all relevant legislation and guidelines, including the Information Privacy 
Principles defined in the Privacy Act 1988 and ethical principles and standards defined by the 
National Health and Medical Research Council Guidelines for Human Research Ethics 
Committees. 
Statistical linkage key SLK581 is an example of such a data linkage key. SLK581 is a series of 
data elements that have been found to prove useful for inclusion in a data set if that data set 
is to be used for future linkage. The SLK581 is not considered to be ‘personal information’ in 
the same way as name and address, and cannot be reverse engineered to provide such 
personal information. 
Analysis of the efficacy of SLK581 has shown it to be highly deterministic in linkage 
practices; however, its effectiveness can be maximised through the use of extra data items 
(such as full names, postcode, or date of death). It is recommended that these data elements 
are collected in any data sets used in monitoring neonatal hearing screening. Box 2 explains 
SLK581. 
Box 2: Linking data using Statistical Linkage Key SLK581 
In Australia, many community service program data collections developed over the last 
decade, including several for aged care programs, contain a statistical linkage key (SLK) to 
enable derivation of client-level data. In addition, a common SLK is now used in many 
collections to facilitate the statistical examination of cross-program use. SKL581 is: 
3 letters of surname + 2 letters of given name (5) — Date of birth (8) — Sex (1) 
SLK581 can be calculated and added as a variable to the dataset before sharing this data set. 
This allows the removal of identifying information and thus protects privacy while enabling 
linkage with other data sets. 
 
An example of how SLK581 works:  
For example, Dorothy Windsor 08/06/1921 F  
SLK-581 would be INSOR08061921F  
Appendix D provides a list of data elements necessary to calculate nationally consistent 
performance indicators. Those data elements necessary to create an appropriate linkage key 
are identified by a ‘key’ () icon.  
1.5.3.4 Data standards 
The data elements included in Appendix D were defined at the time of the indicator 
development. As data standards are continually updated, the most recent standards should 
be used when using these indicators.  
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Geographic identifier to calculate socioeconomic status and remoteness  
To calculate socioeconomic status and remoteness, the NDSS recommends that a geographic 
identifier of usual residence is collected. Ideally this should be consistent with current 
geocoding standards. At the time of the indicator development, this was the Australian 
Standard Geographical Classification (ASGS). This was replaced by the Australian Statistical 
Geography Standard in 2011 (ABS 2011). The combination of locality, state and postcode 
should provide enough information to allocate a suitable geographic identifier; however, in 
the absence of technology to derive a geocode, postcode will provide an acceptable 
alternative.  
1.5.3.5 Privacy and methodological consideration of small numbers 
Some of the indicators rely on data from a small number of infants, especially where data are 
disaggregated by different population subgroups. Reporting categories with a small number 
of cases has privacy and ethical concerns as it may be possible to identify the persons whom 
the data represent. Additionally, data reliability is questionable when rates are based on only 
a small number of cases, or a small population, as may be the case with neonatal hearing 
screening follow-up. In both these instances it can be almost impossible to distinguish 
random fluctuation over time or between different population groups from real differences 
or trends.  
Consequently, performance indicators later in the screening pathway may not have sufficient 
data to disaggregate by population subgroups and may need to be calculated and reported 
over multiple years. 
1.5.4 State and territory considerations 
Infants who have contact with neonatal hearing service providers outside their jurisdiction of 
(the mother’s) residence are at increased risk of being lost to follow-up and not receiving the 
support and services they need. The issue of which jurisdiction should be responsible for 
monitoring the progress of infants through the screening pathway needs to be considered.  
The NDSS recommend that for the purposes of reporting by jurisdiction, the jurisdiction 
responsible for monitoring an infant’s progress through the screening pathway should be the 
jurisdiction of screen. It is noted that the jurisdictions currently liaise to ensure these infants 
are adequately followed up. 
Performance data for each stage of the screening pathway (participation, screening, 
audiological assessment and diagnosis, and early intervention and management) is 
recommended to be presented by jurisdiction of activity. This means that for example, when 
calculating indicators that use screening data (Indicator 1 Participation and Indicator 2 
Screening) jurisdiction of screen is used, while when calculating audiological assessment 
indicators, jurisdiction of audiological assessment is used. 
1.5.5 Ongoing refinement and development 
Indicator development is an iterative process. To ensure the indicators remain relevant and 
valid, they should be regularly reviewed and refined. 
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2 Performance indicator development  
Performance indicators are regularly used to monitor diseases, conditions and health-related 
interventions such as screening. The principles and methodology underpinning indicator 
development are outlined in section 2.1. 
Recently in Australia, the specification of performance indicators has become more 
formalised due to the need to support comparative reporting under the various agreements 
entailed in the Intergovernmental agreement on federal financial relations (COAG 2008). The 
formalisation takes two main forms: the ‘metadata’ relating to the indicator specification, and 
the data quality statement that accompanies the reporting of the indicator. These are 
discussed further in section 2.2. 
2.1 Performance indicator development principles 
and methodology 
2.1.1 Performance indicator principles 
A health performance indicator can be defined as a statistic or other unit of information that 
reflects, directly or indirectly, for a population or an individual: 
• an aspect of health 
• a change in an aspect of the health status 
• the performance of a health intervention, facility, service or system. 
The value of a formally-endorsed performance indicator is that it consistently reports a 
single concept that can be interpreted in the context of changing policies and guidelines.  
Performance indicators are developed against the selection criteria outlined in Box 2.1. 
 
Box 2.1: Selection criteria for developing performance indicators 
Performance indicators should meet some or all of the following criteria: 
1. Be worth measuring 
2. Be measurable for diverse populations 
3. Be understood by people who need to act 
4. Galvanise action 
5. Be relevant to policy and practice 
6. Reflect results of actions when measured over time 
7. Be feasible to collect and report 
8. Comply with national processes of data definitions. 
Source: National Health Performance Committee 2001. 
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It is important to note that the availability of data is not a criterion in selecting a performance 
indicator; however, a potential performance indicator should be capable of being measured 
(that is, capable of having data collected to calculate the performance indicator value).  
Importantly, a core set of performance indicators cannot be expected to meet every need for 
information, and performance indicators are not a substitute for research and policy analysis. 
Additional performance indicators may be nominated to monitor other aspects of policy, 
practice or guidelines, but will not be considered core. Based on previous AIHW experience 
in developing national performance indicators, a core set would generally comprise fewer 
than 10 performance indicators.  
2.2 Data concepts 
In order to effectively measure performance of neonatal hearing screening in Australia, it is 
necessary to use quality data which are defined by standards. Data elements used to 
compute performance indicators should have standardised definitions and collection 
methods across all jurisdictions so that this information may be compared and used to 
monitor neonatal hearing screening against its objectives.  
2.2.1 Data elements 
Data elements are the basic unit of identifiable and definable information. A number of data 
elements and standards relating to health are defined in National Minimum Data Sets and 
Data Set specifications and are published as the National health data dictionary (NHDD). 
The NHDD contains standard data definitions and data elements for use in Australian health 
data collections. It is a source of information about endorsed national metadata standards 
and provides the basis for consistent national collection and reporting. The national 
metadata standards are approved by the Australian government and all state and territory 
relevant health services departments as well as the Australian Bureau of Statistics (ABS) and 
the AIHW.  
Under these agreements, all parties agree to ensure that the collection, compilation and 
interpretation of national information is appropriate and is carried out efficiently. This 
requires agreement on definitions, standards and rules of collection of information and on 
guidelines for the coordination of access, interpretation and publication of national health 
information. 
The data elements necessary to monitor the performance indicators for neonatal hearing 
screening are listed in Appendix D. Where possible, existing data elements were identified in 
national data dictionaries; however, a number of data elements specific to neonatal hearing 
will need to be developed.  
2.2.2 Metadata 
Metadata, loosely translated as ‘data about data’, covers the detailed specification of a 
performance indicator such as numerator, denominator, relevant population, time period, 
target/change, measurement details, and possibly a nominated data collection. Metadata are 
included in the technical specifications outlined in Chapter 4. 
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2.2.3 Data quality statements 
Despite best intentions in performance indicator development, often there are gaps between 
the real world, the data relating to the real world, and the concept being expressed by an 
indicator. Data quality statements are useful in describing and understanding the gap 
between the data collected and the performance indicator as specified. A quality statement 
shows the degree of compliance with the formal specification, and helps users interpret the 
results of indicator data.  
2.2.4 METeOR and the National Indicator Catalogue  
Part of the formalisation of performance indicator specification in the context of the 
Intergovernmental agreement on federal financial relations (COAG 2008) is the inclusion of 
performance indicator metadata in the AIHW metadata online register (METeOR). The 
development of performance indicators in METeOR improves quality, relevance, consistency 
and the availability of national information about the health and welfare of Australians. 
To assist people to access performance indicator metadata, the National Indicator Catalogue 
has been established—a web-based search tool containing many of the performance 
indicators used in Australia. The National Indicator Catalogue can be accessed at 
<www.aihw.gov.au/national-catalogue-indicator/>.  
Implementation of the indicators in this working paper should include the development of a 
data quality statement, a data set containing the data elements required for reporting and 
registration in METeOR and the National Indicator Catalogue. 
2.3 The current indicator set 
National performance indicators provide a framework by which to measure whether 
neonatal hearing screening in Australia is achieving its aims and objectives. This will help 
improve and strengthen nationally consistent screening practices and administrative 
processes to further improve outcomes for Australian infants.  
 
Figure 2.1: Service, jurisdictional and national level reporting and monitoring 
 
• National Framework 
for Neonatal 
Hearing Screening 
Service delivery level 
• Performance indicators Jurisdictional level 
• National performance indicators National 
 level 
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National performance indicators should complement routine monitoring and reporting by 
jurisdictions and services. Figure 2.1 shows the relationship between service delivery-, 
jurisdictional- and national-level analysis and reporting. Monitoring at the national level is 
less detailed than at a service or jurisdictional level. 
The process undertaken to develop the proposed national performance indicator set for 
neonatal hearing screening is described in the following sections. 
2.1.2 Performance indicator development methodology 
Indicator development is an iterative process, commencing with a review of relevant 
policies, strategies, statements and guidelines, and cataloguing existing performance 
indicators. This feeds into a ‘refinement’ stage, including seeking stakeholder feedback and 
assessing potential performance indicators against the selection criteria. This process is 
summarised in Figure 2.2. 
 
Figure 2.2: Process for indicator development  
2.3.1 Objective 
Under the direction of the NHSWG, the AIHW convened a Neonatal Data Specification 
Subgroup (NDSS) to oversee and coordinate the development of a core set of national 
performance indicators and data elements for reporting and analysis of neonatal hearing 
screening in Australia. The composition of the group was designed to take advantage of the 
knowledge and experience of the personnel involved in neonatal hearing screening service 
and delivery in Australia, and performance indicator development. The NDSS members 
involved in this process are listed in Appendix B. 
The national performance indicators were chosen to be consistent with the aims and 
objectives for neonatal hearing screening outlined in the National Framework for Neonatal 
Hearing Screening (NHSWG 2013) to provide a basis for monitoring and evaluating the 
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effectiveness of neonatal hearing screening in Australia. The 29 objectives, 69 standards and 
83 targets described in the framework were used as a starting point for the indicator 
development. 
The NDSS also undertook a review of relevant literature and frameworks, of performance 
indicators for other screening programs (such as BreastScreen Australia and the National 
Cervical Screening Program), and of jurisdictional and international performance indicators 
for monitoring neonatal hearing screening to provide further information and guidance in 
developing the indicators.  
2.3.2 Boundary, scope and approach 
During the indicator development process, a number of decisions were made with regard to 
appropriate boundary, scope and approach of the work. These are listed below. 
• The national performance indicators should:  
– support (not replace) the objectives, standards and targets described in the National 
Framework for Neonatal Hearing Screening (NHSWG 2013)  
– supplement jurisdictional and service-level reporting already routinely conducted 
by providing a high level measure of performance of neonatal hearing screening in 
Australia. 
• Only quantitative objectives, standards and targets from the Draft National Framework 
(later titled the National Framework for Neonatal Hearing Screening, NHSWG 2013) 
were considered for potential inclusion. Quantitative objectives were considered to be 
more appropriately measured at the service provision or jurisdictional level. 
• Consideration was given to the fewest number of indicators that would appropriately 
measure performance of neonatal hearing screening in Australia. Performance indicators 
appropriate for monitoring at a national level should be robust enough to appropriately 
measure performance of neonatal hearing screening against its aims and objectives, while 
imposing minimal reporting burden to allow services and jurisdictions to more 
appropriately use resources in program management. As a result, indicators were 
proposed that:  
– cover the key guidelines and strategy objectives of neonatal hearing screening; 
– cover these with a certain efficiency 
– provide a degree of compliance with the APHDPC Population Based Screening 
Framework and World Health Organization (WHO) principles of early disease 
detection (Wilson 1968) 
– enable flexibility/scalability of reporting depending on the data source. 
• As the availability of data is not a criterion in selecting an indicator, the final list contains 
indicators for which data development will need to occur before they can be reported by 
data providers (usually the jurisdictional health services or Australian Hearing) to be 
analysed at a national level. It was noted that a potential performance indicator should 
be capable of being measured (that is, capable of having data collected to calculate the 
indicator).  
• During performance indicator development, it was noted that COAG and the National 
Health Information Standards and Statistics Committee are working to strengthen and 
improve performance monitoring, while reducing and streamlining performance 
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indicators and harmonising data sets. The proposed set of national performance 
indicators were created with this principle in mind. 
2.3.3 Performance indicator development workshop 
The AIHW held a workshop for NDSS members in Canberra in July 2010. The aims and 
objectives of the workshop were to: 
• determine what should be measured and its relevance as a national performance 
indicator 
• consider data availability, appropriateness and reliability 
• identify data elements to support proposed indicators.  
Each of the objectives and targets developed by the NHSWG as part of the Draft National 
Framework (later titled the National Framework for Neonatal Hearing Screening, NHSWG 
2013) were systematically assessed by the NDSS for their utility for national monitoring 
against the selection criteria for developing indicators (see Box 2.1) and compared to national 
performance indicators for screening programs (such as BreastScreen Australia and the 
National Cervical Screening Program) and existing neonatal hearing screening programs in 
Australia, the United States of America, the United Kingdom and New Zealand. 
The workshop participants considered a total of 69 standards and 83 targets. A decision 
matrix summarising the outcomes of the assessment process is presented in Appendix C 
(Table C.1).  
2.3.4 Deciding on the national performance indicators 
Using the decision matrix listed in Appendix C, a list of potential national performance 
indicators, including operational definitions, technical specifications and a list of related data 
elements was developed by the AIHW. These potential national performance indicators were 
assessed by the NDSS using the National Health Performance Framework criteria for 
performance indicator development (Box 2.1) and developed into a short list of indicators. 
Feedback was sought from the NDSS via a series of teleconferences, and finally from 
members of the Screening Subcommittee, from which the composition of the proposed core 
indicator set and related operational definitions was finalised. 
2.3.5 Bringing it all together  
Following the process outlined above, and using the Population based screening framework 
(APHDPCSS 2008), the NDSS identified four areas from the Draft National Framework (later 
titled the National Framework for Neonatal Hearing Screening, NHSWG 2013) as 
appropriate to be monitored using national performance indicators. These are listed below. 
• Participation in the program, which aims to maximise the number of infants screened 
for PCHI 
• Screening, which aims to maximise the identification of infants with potential hearing 
impairment while minimising parental anxiety and cost 
• Audiological assessment and diagnosis, which aims to accurately identify infants born 
with PCHI 
• Early intervention and management, which aims to maximise engagement of infants 
identified as requiring a service with early intervention services. 
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Other areas identified by the NHSWG as central to the effective functioning of neonatal 
hearing screening programs but more appropriately monitored at a jurisdictional or service 
delivery level included parent support; co-ordination, monitoring and evaluation of the 
program; and professional education. Table 2.2 presents the final indicator list. 
Table 2.1: National performance indicators for neonatal  
hearing screening in Australia 
Performance indicators 
Indicator 1 Participation  
 1.1 Participation in screening 
Indicator 2 Screening 
 2.1 Positivity rate of the screening test  
 2.2 Positive predictive value of the screening test 
Indicator 3 Audiological assessment and diagnosis 
 3.1 Audiological assessment 
 3.2 Detection of permanent childhood hearing impairment  
Indicator 4 Early intervention and management 
 4.1 Attend early intervention service 
 4.2 Infants fitted with an assistive hearing device 
 
Figure 2.3 presents a framework for monitoring neonatal hearing screening in Australia and 
illustrates the relationship between the Population-based screening framework (APHDPCSS, 
2008), the National Framework (NHSWG 2013) and the proposed national performance 
indicators and targets. 
Figure 2.4 describes an infant’s progress through the screening pathway noting those points 
at which data is collected for national reporting. The proposed end of the screening pathway 
is contact with Australian Hearing for a hearing and communication improvement program 
or a jurisdictional health service for cochlear implantation, if required. Monitoring of longer 
term outcomes beyond the screening pathway would be facilitated by the use of identified 
data and the development of a data linkage key.  
Together, the National Framework and indicators provide a roadmap to support consistent 
reporting on key indicators across States and Territories which can be followed as their 
screening programs develop and as resources permit.
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Target population: infants eligible for hearing screening Performance indicators Targets
Recruitment
Aim: to maximise the number of eligible infants screened for permanent 
childhood hearing impairment
Screening
Aim: to maximise the identification of infants with 
potential hearing impairment while minimising parental 
anxiety and costly procedures
Assessment and Diagnosis








1.1 Participation in screening 1.1: >97% of eligible infants complete a hearing screen before 1 month corrected age (Framework 
target 2.2.1)
2.1 Positivity rate
2.2 Positive predictive value
2.1: <4% of infants screened test positive for 
potential PCHI and are referred to audiological 
evaluation (Framework target 2.7.2)
2.2: A target for the expected positive predictive 
value of the screening test needs to be developed, 
in the interim it is recommended that the target be 
that the number of infants referred for assessment 
and subsequently diagnosed is appropriate to the 
population and consistent with international 
standards (Framework objective 2.7)
3.1: >97% of infants with a positive screen have 
commenced diagnostic assessment by 3 months 
corrected age (Framework target 4.1.1)
3.2: Approximately 0.1% of infants screened are 
diagnosed with PCHI (Framework target 2.7.1)
4.1: To be developed
4.2: >97% babies diagnosed with a permanent 
hearing loss are referred to Australian Hearing 
(Framework target 5.5.1)
100% of referrals received by Australian hearing 
are confirmed to the referral agency within 5 days 
(Framework target 5.5.2) 
>85% of children diagnosed with bilateral hearing 
loss >40dBHL are fitted with amplification by 6 
months of age (Framework target 5.5.5)
>95% of children diagnosed with bilateral hearing 
loss >40 dBHL are fitted with amplification by 12 
months of age (Framework target 5.5.6)
3.1 Audiological assessment
3.2 Detection of PCHI
4.1 Attended early 
intervention service
4.2 Infants fitted with an 
assistive hearing device
 
Figure 2.3: National neonatal hearing screening monitoring framework 
Note: Because targets are listed as dot points in the National Framework (NHSWG 2013) the numbering of the targets does not refer to the standards in the framework but instead refers to number of the target under the 
relevant objective.
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All infants > 34 weeks gestation born in Australia
Informed consent
Information on NHS and opportunity to discuss NHS provided to parents before birth
Birth of baby DATA
Baby screened DATA




guidelines in the 
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Baby referred directly 
to audiology
Attendance at Australian Hearing or 
state health service for the fitting of an 
assistive hearing devise
Engagement with an early intervention 
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3 National performance indicators 
The indicators were chosen that measure of the aims and objectives of neonatal hearing 
screening as outlined in the National Framework for Neonatal Hearing Screening (NHSWG 2013) 
and are presented in the order that an infant progresses through the screening pathway. 
3.1 How to use the information on indicators 
Indicator 
A statistic or other unit of information that reflects, directly or indirectly, for a population or 
an individual 
• an aspect of health 
• a change in an aspect of the health status 
• the performance of a health intervention, facility, service or system. 
Definition 
The definition is a statement that explains what the indicator is measuring. Along with the 
Technical Specifications (outlined in chapter four) the definition is a clear, concise, 
unambiguous, and comprehensive statement that provides sufficient information to ensure 
all those who collect, provide, analyse and use the data clearly understand its meaning. 
Objective 
An aim of the program, usually presented with an accompanying standard which elaborates 
one component of the aim, and a target that quantifies an outcome. 
Target 
Targets quantify standards and objectives (for example, >97% participation). Because the 
targets are listed as dot points in the National Framework (NHSWG 2010 unpublished) the 
numbering of the targets does not refer to the standards in the framework but instead refers 
to the number of the target under the relevant objective. 
Rationale  
The rationale presents the justification for including the indictor in national reporting. 
Sub-indicator names  
Sub-indicators are components of an indicator. 
Disaggregations 
This section lists how data will be separated into sub-categories (for example, by 
socioeconomic status or age). 
Issues for consideration  
In this section any issues are detailed that require further consideration prior to 
implementation.  
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Indicator 1 Participation  
Indicator 1.1 Participation in screening 
Definition:  
Proportion of infants born in a calendar year who complete a neonatal hearing screen through a jurisdictional neonatal hearing 
screening program.  
National Framework Objectives: 
• 1.1: To enable early identification of all infants with a congenital hearing loss of >40dB HL, including: bilateral, 
unilateral, sensory or neural hearing loss (e.g. Auditory Neuropathy Spectrum Disorder) and permanent conductive 
hearing loss. 
• 2.1: Families are able to make an informed decision on hearing screening and diagnostic services. 
• 2.2: All eligible infants complete a hearing screen. 
National Framework Target:  
• >97% of eligible infants complete a hearing screen before 1 month corrected age (Framework target 2.2.1). 
Rationale:  
This indicator measures the proportion of the population who are screened by a jurisdictional neonatal hearing screening 
program. Higher participation is necessary for achieving the overall aim of improving linguistic, educational and social outcomes 
for infants born with PCHI. Early identification of PCHI allows early engagement with intervention services which research has 
shown is necessary for achieving the overall aim of improving linguistic, educational and social outcomes for infants with 
permanent hearing loss. Therefore, it is necessary to monitor the age at which screening is occurring so the program is being 
run to maximum benefit.  
Because the age at which an infant completes their neonatal hearing screen is closely tied to the identified aim of improving 
outcomes for infants born with PCHI, the calculation associated this indicator will present data disaggregated by age. 
Calculation:  
This calculation measures the number of infants who complete a neonatal hearing screen through a jurisdictional screening 
program as a proportion of all infants born in a calendar year.  
Disaggregation: 
The data will be presented by the following stratifications: 
• Jurisdiction  
• Sex 
• Remoteness  
• Socioeconomic status 
• Aboriginal and Torres Strait Islander status  
• CALD  
• Preterm birth 
• Age completed screen – disaggregated as <1 month, 1–3 months, 3–6 months, >6 months corrected age. 
Issues for consideration: 
• Infants who do not enter the screening pathway before being discharged from hospital may be at a higher risk of not 
completing a hearing screen. To ensure equitable access for all infants, those who do not enter the screening 
pathway by receiving at least their first screen prior to discharge should be followed up to ensure they complete their 
hearing screen. It is noted that this is a jurisdictional issue best monitored at the jurisdictional level. 
• The denominator should be the number of live births. The National Perinatal Data Collection (NPDC) provides a 
comprehensive validated dataset of all live births in Australia, but is only is available after a two-year delay. 
State/territory neonatal screening programs are able to provide a suitable and timely alternative. 
• While the aim of neonatal hearing screening is for all infants to be screened for congenital PCHI by 4 weeks of 
(corrected) age, the National Framework (NHSWG 2013) restricts this to eligible infants. Infants who are not eligible 
for screening include infants deemed to be medically unfit for screening. It is anticipated that this subgroup of infants 
will be very small and best monitored at the jurisdictional level. 
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Indicator 2 Screening  
Indicator 2.1 Positivity rate of the screening test 
Definition:  
The proportion of infants who are screened and test positive for potential permanent childhood hearing impairment.  
National Framework Objective 2.7:  
To ensure that the number of infants referred for assessment and subsequently diagnosed with the target condition is 
appropriate for the population and is consistent with international standards. 
National Framework Target:  
• <4% of infants who are screened test positive for potential PCHI and are referred for audiological evaluation 
(Framework Target 2.7.2). 
Rationale:  
The positivity rate of the screening test provides an indication of how well the screening test is functioning as a test of potential 
PCHI. Current research suggests that a positivity rate higher than 4% could mean the screening test is yielding too many false 
positives (NHSWG, 2010). Additionally, a positivity rate higher than 4% (along with the confirmed diagnosis rate) may be an 
indication of an increase in PCHI among infants in Australia which would be a public health concern. 
Another indication of how well the screening test is functioning can be obtained from the positive predictive value of the 
screening test, which is the proportion of infants who receive a positive hearing screen who after further examination are 
diagnosed with PCHI. The disaggregations for this indicator will ensure that the screening test is performing equally for all 
population subgroups.  
Calculation:  
This calculation measures the number of infants who returned a positive neonatal hearing screen as a proportion of all infants 
screened. 
Disaggregations: 
The data will be presented by the following stratifications: 
• Jurisdiction  
• Sex 
• Remoteness  
• Socioeconomic status 
• Aboriginal and Torres Strait Islander status 
• CALD  
• Preterm birth 
• Age – disaggregated as <1 month, 1–3 months, 3–6 months, >6 months corrected age. 
Issues for consideration: 
• The two approved screening technologies, OAE and AABR, have different positivity rates (i.e. AABR should be <2%, 
OAE <4%). 
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Indicator 2.2 Positive predictive value of the screening test  
Definition:  
The proportion of infants who test positive on their screening test for potential PCHI and upon further assessment receive a 
definitive diagnosis of PCHI.  
National Framework Objective 2.7:  
To ensure that the number of infants referred for assessment and subsequently diagnosed with the target condition is 
appropriate for the population and is consistent with international standards. 
National Framework Target:  
• A target for the expected positive predictive value of the screening test needs to be developed, in the interim it is 
recommended that the target be that the number of infants referred for assessment and subsequently diagnosed is 
appropriate to the population and consistent with international standards (Framework objective 2.7). 
Rationale:  
Currently, a combination of the otoacoustic emissions (OAE) test and the automated auditory brainstem response (AABR) test 
are used as the screening procedure for neonates in Australia. The screening process in neonatal hearing screening, like other 
screening tests, is not intended to be diagnostic. Rather, screening aims to identify infants who are more likely to have hearing 
impairment, and therefore require further investigation from diagnostic tests. 
In order to understand the characteristics of the screening test, it is useful to compare the results of screening tests performed 
with the ‘truth’. To do this, the number of infants with a positive screening test who are subsequently diagnosed with PCHI is 
viewed as a proportion of the number of infants with a positive screening test. These data can also be used to compute the 
number of false positives the screening test is yielding. It is important to monitor how well the screening test is functioning to 
ensure the screening process does not cause unnecessary anxiety or distress to families; and that the program is not 
unnecessarily resource intensive by referring too many infants for further investigation.  
Indicator 2.2 is an important indicator to be interpreted in conjunction with indicator 2.1 as it ensures that of the infants who are 
being referred to audiological assessment, an appropriate number of these infants are found to have the target condition.  
Calculation:  
The number of infants who test positive on their screening test for potential PCHI and upon further assessment are given a 
definitive diagnosis of PCHI as a proportion of all infants who test positive for potential PCHI. 
Disaggregations:  
The data will be presented by the following stratifications: 
• Jurisdiction  
• Sex 
• Remoteness  
• Socioeconomic status 
• Aboriginal and Torres Strait Islander status 
• CALD  
• Preterm birth 
• Age – disaggregated as <1 month, 1–3 months, 3–6 months, >6 months corrected age. 
Issues: 
• In the short term, it is recommended that the target for this indicator be that the number of infants diagnosed with 
PCHI is appropriate for the population and consistent with international standards. Research needs to be conducted 
as to the incidence of PCHI in Australia. In the long term, an appropriate target for this indicator needs to be 
researched and developed.  
— According to the Medical Services Advisory Committee’s Universal Neonatal Hearing Screening 
Assessment Report (2007) the PPV of TEOAE is 1.5% and of AABR is 2.2%. Research needs to be 
conducted on the PPV of the screening process that is used by jurisdictional screening programs. 
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Indicator 3 Audiological assessment and 
diagnosis 
Indicator 3.1 Audiological assessment  
Definition:  
The proportion of infants who test positive for potential PCHI that complete audiological assessment.  
National Framework Objectives: 
• 2.6 To ensure infants identified at risk of PCHI are referred for assessment in a timely manner.  
• 4.1 To ensure that infants who meet the defined criteria for referral receive follow-up audiological and medical 
evaluations in a timely manner.  
National Framework Target:  
• >97% diagnostic audiology assessment is commenced by three months of corrected age (Framework target 4.1.1). 
Rationale:  
This indicator measures the proportion of infants who returned a positive neonatal hearing screen and complete diagnostic 
assessment. It is important to ensure that infants who are referred to audiological assessment following a positive screen 
receive that assessment so they can continue to receive an intervention as appropriate. 
Calculation:  
This calculation measures the number of screened infants who test positive for potential PCHI and complete audiological 
assessment as a proportion of all infants who test positive on their screening test. 
Disaggregations:  
The data will be presented by the following stratifications: 
• Age of infant when completed audiological assessment – disaggregated as <1 month, 1–2 months, 2–4 months, 4–6 
months, >6 months corrected age 
• Jurisdiction.  
Issues: 
• The NDSS recommends the below National Framework target >97% of infants diagnosed with a permanent hearing 
loss are referred to Australian hearing (Framework target 5.5.1) be considered as a target for this indicator. Adding a 
time element could improve this target.  
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Indicator 3.2 Detection of permanent childhood hearing impairment 
Definition:  
The proportion of infants who are diagnosed with PCHI.  
National Framework Objective 2.7:  
To ensure that the number of infants referred for assessment and subsequently diagnosed with the target condition is 
appropriate for the population and is consistent with international standards. 
National Framework Target:  
• Approximately 0.1% of infants screened are diagnosed with the target condition (Framework target 2.7.1). 
Rationale:  
The detection of PCHI is an indicator of program performance. Variation in this indicator over time could indicate an increase in 
the incidence of PCHI or that the screening and diagnostic instruments are not functioning properly.  
When expressed as a proportion of the number of infants who test positive for potential PCHI, these data form Indicator 2.2 
positive predictive value of the screening test. 
Annual monitoring of these data with various stratifications (such as age or location) may reveal findings of concern that need to 
be addressed by the program, or positive trends that let the program know it is performing well. 
This indicator will also monitor the age that PCHI is diagnosed.  
Calculation:  
This calculation measures the number of screened infants who are diagnosed with PCHI as a proportion of all infants screened. 
Disaggregations:  
The data will be presented by the following stratifications: 
• Age at diagnosis – disaggregated as <2 months, 2–4 months, 4–6 months, >6 months corrected age 
• Jurisdiction  
• Degree, configuration and type of hearing loss. 
Issues: 
• The disaggregation of age at diagnosis (presently <2 months, 2–4 months, 4–6 months, >6 months corrected age) 
needs to be agreed upon.  
• A further issue that requires consideration is whether infants are diagnosed with either congenital permanent 
childhood hearing impairment or no congenital childhood hearing impairment or whether there are other possible 
diagnoses. 
• Hearing status for any individual person is not static. For the purposes of newborn hearing screen, this indicator’s 
definition could be hearing status based on a completed newborn audiological assessment, with a maximum age at 
assessment of 6 months. 
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Indicator 4 Early intervention and management  
Indicator 4.1 Attend early intervention service 
Definition:  
The proportion of infants diagnosed with PCHI who attend an early intervention service. 
National Framework Objective: to be created  
To ensure that families and infants engage with an early intervention service. 
National Framework Target:  
• A suitable target needs to be created.  
Rationale:  
It is important that infants who are diagnosed with PCHI attend early intervention services. This is necessary to achieve the 
program’s overall aim of improving linguistic, educational and social outcomes for infants with congenital hearing loss which is of 
clear benefit to the infant, family and the community.  
It is important to capture these data to monitor the reasons infants are not progressing through the screening pathway as the 
National Framework (NHSWG 2013) posits that all eligible infants should proceed as far through the screening pathway as their 
hearing status warrants so that all Australian infants can benefit from the best possible linguistic, educational and social 
outcomes. Legitimate reasons that infants may not progress through the screening pathway include the family not consenting, 
or the infant having other medical problems that prevent attendance. 
Indicator 4.1 compares the number of infants diagnosed with PCHI who attend an early intervention service as a proportion of 
the number of infants diagnosed with PCHI whose parents are referred to early intervention. This is because infants who are 
captured in Indicator 4.1 should be referred through the program. 
Calculation:  
This calculation measures the number of infants diagnosed with PCHI and attend early intervention services as a proportion of 
the number of infants diagnosed with PCHI.  
Disaggregations 
The data will be presented by the following stratifications: 
• Jurisdiction  
• Age at attendance at early intervention services – disaggregated as <2 months, 2–4 months, 4–6 months, >6 months 
corrected age 
• Time (weeks) elapsed between date of completing diagnostic services and attending early intervention services – 
disaggregated as <6 weeks, 6–9 weeks, 9–12 weeks, >12 weeks. 
Issues: 
• A suitable objective and target need to be created. A possible objective could be To ensure that families and infants 
engage with an early intervention service. 
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Indicator 4.2 Infants fitted with an assistive hearing device  
Definition:  
The proportion of infants diagnosed with PCHI who are fitted with an assistive hearing device.  
National Framework Objective:  
Infants who have a permanent, moderate or greater bilateral sensorineural hearing loss are provided with amplification/implants 
in an appropriate time frame for optimal speech and language development. 
National Framework Target:  
• >97% babies diagnosed with a permanent hearing loss are referred to Australian Hearing (Framework target 5.5.1). 
• 100% of referrals received by Australian hearing are confirmed to the referral agency within 5 days (Framework target 
5.5.2). 
• >85% of children diagnosed with bilateral hearing loss >40 dBHL are fitted with amplification by 6 months of age 
(Framework target 5.5.5). 
• >95% of children diagnosed with bilateral hearing loss >40 dBHL are fitted with amplification by 12 months of age 
(Framework target 5.5.6). 
Rationale:  
It is appropriate to monitor factors around hearing aid fitting and cochlear implants. Monitoring these data will assist in service 
provision and understanding of the types of devices commonly used. It is important to note that audiological management of a 
hearing impaired child may not always involve a device fitting.  
Calculation:  
This calculation measures the number of infants who are fitted with an assistive hearing device as a proportion of all infants 
diagnosed with PCHI. 
Disaggregations: 
The data will be presented by the following stratifications: 
• Jurisdiction  
• Age at fitting of first assistive hearing device – disaggregated as <2 months, 2–4 months, 4–6 months, >6 months 
corrected age 
• Type of first assistive hearing device – hearing aid, cochlear implant, other. 
Issues: 
• Australian Hearing can report on hearing aids. Jurisdictional health departments should report on cochlear implant 
fitting.  
• The following Framework targets could be considered after initial implementation:  
— 5.3.1 Age of initiation of formal early intervention is recorded centrally in the program for all children 
diagnosed with permanent hearing impairment. 
— 5.3.2 >97% of babies with permanent hearing impairment are engaged in formal early intervention by four 
months of corrected age. 
— 5.5.3 >97% of families attend appointment within three weeks of the referral.  
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4 Technical specifications  
Chapter 4 presents clear and concise technical information for each indicator to ensure all 
those who collect, provide, analyse and use the data clearly understand its meaning.  
4.1 How to use the information on technical 
specifications 
Formula  
This section provides the conceptual formula that is needed to compute the indicator. 
Numerator and denominator definitions 
This section elaborates on the formula providing the information necessary to compute the 
formula such as specifying the boundary of data included for example for one calendar year.  
Numerator and denominator data collection  
The data collection is the name of the data collection from which the data elements were 
derived. 
Numerator and denominator data source  
The data source refers to the source of the data for the indicator; for some indicators the 
numerator and denominator data source will be different.  
Data elements 
The basic unit of identifiable and definable information: 
• Selection data elements refer to data elements necessary to compute the indicator. 
• Disaggregation data elements refer to data elements necessary to disaggregate the 
indicator, for example by socioeconomic status or jurisdiction of birth. 
Numerator and denominator specifications 
This section may include information on how to calculate components of an indicator, such 
as corrected age; and what values of a data element to include to calculate an indicator, for 
example to only include infants with a diagnosis of PCHI when using the data element 
Audiological assessment outcome. 
Multiplication factor 
The multiplication factor is a number that the formula is multiplied by for ease of 
interpretation, for example a multiplication factor of 100 turns the participation indicator into 
a rate of per 100 infants otherwise known as a per cent.  
Unit 
The unit refers to the unit of measurement used in that indicator, for example infants or 
screening tests. 
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Indicator 1 Participation 
Indicator 1.1 Participation in screening  
 
Formula 
Number of infants born in a calendar year who complete a hearing screen 




Numerator definition: Number of infants born in a calendar year who complete a hearing screen. 
Numerator data 
collection: 
Jurisdictional neonatal hearing screening program register data collection. 
Numerator data 
source:  
Jurisdictional neonatal hearing screening programs. 
Numerator data 
elements: 
Selection data elements: 
Date of birth 
Date screen completed 
Disaggregation data elements: 
Jurisdiction 
 Sex 
 Geographic identifier of usual residence  





• While the aim of neonatal hearing screening is for all infants to be screened for congenital 
PCHI by 4 weeks of (corrected) age, the National Framework for Neonatal Hearing 
Screening (NHSWG 2013) restricts this to eligible infants. Infants who are not eligible for 
screening include infants deemed to be medically unfit for screening. It is anticipated that 
this subgroup of infants will be very small and best monitored at the jurisdictional level. 
• Count is of all infants born in the designated calendar year where date screen completed is 
NOT NULL. 
• Corrected age is calculated as chronological age at screen less gestational age. 
• Chronological age at screen is calculated by subtracting date of birth from date screen 
completed. 
• Geographic identifier of usual residence is used to calculate remoteness and 
socioeconomic status, Statistical Local Area (or equivalent) is preferred; however postcode 
is an acceptable alternative. 
• CALD should be identified through standard questions as per 2006 census. Country of birth 
of mother (as collected in the NPDC) could be used as a proxy, but only partially represents 
an infant’s cultural heritage. 
• Identification of an infant as Aboriginal and Torres Strait Islander is based on identification 
to the jurisdictional register or Australian Hearing by the infant’s family. Aboriginal and 
Torres Strait Islander status of mother (as collected in the NPDC) could be used as a proxy, 
but only partially represents an infant’s Indigenous heritage. 
 




The number of infants born in a calendar year. 
Denominator data 
collection: 
Jurisdictional neonatal hearing screening program register data collection. 
NB: This can be validated after a 2-year period by National Perinatal Data Collection. 
Denominator data 
source: 
Jurisdictional neonatal hearing screening programs. 
National Perinatal Epidemiology and Statistics Unit, AIHW. 
Denominator data 
elements: 
Selection data elements: 
Date of birth 




• While the aim of neonatal hearing screening is for all infants to be screened for congenital 
PCHI by 4 weeks of (corrected) age, the National Framework for Neonatal Hearing 
Screening (NHSWG 2013) restricts this to eligible infants. Infants who are not eligible for 
screening include infants deemed to be medically unfit for screening. It is anticipated that 
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Indicator 2 Screening 
Indicator 2.1 Positivity rate of screening test 
 
Formula 
Number of infants who returned a positive neonatal hearing screen 




Numerator definition: Number of infants born in a calendar year who returned a positive neonatal hearing screen. 
Numerator data 
collection: 
Jurisdictional neonatal hearing screening program registers. 
Numerator source:  Jurisdictional neonatal hearing screening programs. 
Numerator data 
elements: 
Selection data elements: 
 Date of birth 
 Date screen completed 
 Screen outcome 
Disaggregation data elements: 
 Jurisdiction 
 Sex 
 Geographic identifier of usual residence  
 Indigenous identifier 
 CALD identifier 
Numerator 
specifications: 
• Count is of all infants born in the designated calendar year where screen outcome is 
positive. 
• Geographic identifier of usual residence is used to calculate remoteness and 
socioeconomic status, Statistical Local Area (or equivalent) is preferred; however postcode 
is an acceptable alternative. 
• Identification of an infant as Aboriginal and Torres Strait Islander is based on identification 
by the infant’s family to the jurisdictional register or Australian Hearing. Aboriginal and 
Torres Strait Islander status of mother (as collected in the NPDC) could be used as a proxy, 
but only partially represents an infant’s Indigenous heritage. 
• CALD should be identified through standard questions as per 2006 census. Country of birth 
of mother (as collected in the NPDC) could be used as a proxy, but only partially represents 
an infant’s cultural heritage. 
• Measured once in a calendar year at a national level – may be measured more frequently at 





Number of infants born in a calendar year who completed a neonatal hearing screen. 
Denominator data 
collection: 
Jurisdictional neonatal hearing screening program register data collection. 
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Denominator data 
source: 
Jurisdictional neonatal hearing screening programs. 
Denominator data 
elements:  
Selection data elements: 
Date of birth 
Date screen completed 
Disaggregation data elements: 
Jurisdiction of birth 
Sex 
Geographic identifier of usual residence  
Indigenous identifier 
CALD identifier  
Denominator 
specifications: 
• Count is of all infants born in the designated calendar year with date screen completed NOT 
NULL. 
• Geographic identifier of usual residence is used to calculate remoteness and 
socioeconomic status, Statistical Local Area (or equivalent) is preferred; however postcode 
is an acceptable alternative. 
• Identification of an infant as Aboriginal and Torres Strait Islander is based on identification 
to the jurisdictional register or Australian Hearing by the infant’s family. Aboriginal and 
Torres Strait Islander status of mother (as collected in the NPDC) could be used as a proxy, 
but only partially represents an infant’s Indigenous heritage. 
• CALD should be identified through standard questions as per 2006 census. Country of birth 
of mother (as collected in the NPDC) could be used as a proxy, but only partially represents 
an infant’s cultural heritage. 
• Measured once in a calendar year at a national level – may be measured more frequently at 
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Indicator 2.2 Positive predictive value of the screening test 
 
Formula 
Number of infants who returned a positive neonatal hearing screen and subsequently diagnosed with PCHI 




Numerator definition: Number of infants born in a calendar year who returned a positive neonatal hearing screen and were 
subsequently diagnosed with PCHI. 
Numerator data 
collection: 
To be determined. 
Numerator data 
source:  
To be determined. 
Numerator data 
elements: 
Selection data elements: 
Date of birth 
Date screen completed 
Screen outcome 
Audiological assessment outcome 
Disaggregation data elements: 
Jurisdiction  
Sex 
Geographic identifier of usual residence  
Indigenous identifier 
CALD identifier  
Numerator 
specifications: 
• Count is of all infants born in the designated calendar year where screen outcome is 
positive and audiological assessment outcome is positive. 
• Geographic identifier of usual residence is used to calculate remoteness and 
socioeconomic status, Statistical Local Area (or equivalent) is preferred; however postcode 
is an acceptable alternative. 
• Identification of an infant as Aboriginal and Torres Strait Islander is based on identification 
to the jurisdictional register or Australian Hearing by the infant’s family. Aboriginal and 
Torres Strait Islander status of mother (as collected in the NPDC) could be used as a proxy, 
but only partially represents an infant’s Indigenous heritage. 
• CALD should be identified through standard questions as per 2006 census. Country of birth 
of mother (as collected in the NPDC) could be used as a proxy, but only partially represents 
an infant’s cultural heritage. 
• Measured once in a calendar year at a national level – may be measured more frequently at 
a jurisdictional level. 
 
  




Number of infants born in a calendar year who returned a positive neonatal hearing screen. 
Denominator data 
collection: 
Jurisdictional neonatal hearing screening program register data collection. 
Denominator data 
source: 
Jurisdictional neonatal hearing screening programs. 
Denominator data 
elements: 
Selection data elements: 
Date of birth 
Date screen completed 
Screen outcome 
Disaggregation data elements: 
Jurisdiction  
Sex 
Geographic identifier of usual residence  
Indigenous identifier 
CALD identifier  
Denominator 
specifications 
• Count is of all infants born in the designated calendar year where screen outcome is 
positive. 
• Geographic identifier of usual residence is used to calculate remoteness and 
socioeconomic status, Statistical Local Area (or equivalent) is preferred; however postcode 
is an acceptable alternative. 
• Identification of an infant as Aboriginal and Torres Strait Islander is based on identification 
to the jurisdictional register or Australian Hearing by the infant’s family. Aboriginal and 
Torres Strait Islander status of mother (as collected in the NPDC) could be used as a proxy, 
but only partially represents an infant’s Indigenous heritage. 
• CALD should be identified through standard questions as per 2006 census. Country of birth 
of mother (as collected in the NPDC) could be used as a proxy, but only partially represents 
an infant’s cultural heritage. 
• Measured once in a calendar year at a national level – may be measured more frequently at 
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Indicator 3 Audiological assessment and 
diagnosis  
Indicator 3.1 Audiological assessment 
 
Formula 
Number of infants who returned a positive neonatal hearing screen who complete audiological assessment  








To be determined. 
Numerator data 
source:  
To be determined. 
Numerator data 
elements: 
Selection data elements: 
Date of birth 
Date screen completed 
Screen outcome 
Date audiological assessment completed  





• Count is of all infants born in the designated calendar year with date screen completed NOT 
NULL and screen outcome is positive AND date audiological assessment completed is NOT 
NULL. 
• Chronological age at completion of audiological assessment is calculated by subtracting 
date of birth from date audiological assessment completed. 
• Corrected age is calculated as chronological age at audiological assessment less 
gestational age. 
• Time (days) elapsed from completion of screening test to completion of audiological 
assessment is calculated as the difference (in days) between date screen completed and 
date audiological assessment completed – disaggregated as <6 days, 6–10 days, 10–15 





Number of infants born in a calendar year who returned a positive neonatal hearing screen. 
Denominator data 
collection: 
Jurisdictional neonatal hearing screening program registers. 
Denominator data 
source: 
Jurisdictional neonatal hearing screening programs. 
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Denominator data 
elements: 
Selection data elements: 
Date of birth 
Date screen completed 
Screen outcome 




• Count is of all infants born in the designated calendar year with date screen completed NOT 
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Indicator 3.2 Detection of PCHI 
 
Formula 
Number of infants screened through the program who are diagnosed with PCHI 








To be determined. 
Numerator data 
source:  
To be determined. 
Numerator data 
elements: 
Selection data elements: 
Date of birth 
Date screen completed 
Audiological assessment outcome  
Disaggregation data elements: 
Jurisdiction 
Type and degree of hearing loss 
Numerator 
specifications: 
• Count is of all infants born in the designated calendar year where date screen completed 




Number of infants born in a calendar year who complete a neonatal hearing screen. 
Denominator data 
collection: 
Jurisdictional neonatal hearing screening program registers. 
Denominator data 
source: 
Jurisdictional neonatal hearing screening programs. 
Denominator data 
elements: 
Selection data elements: 
Date of birth 
Date screen completed 












  Cancer and Screening Unit Working Paper 35 
Indicator 4 Early intervention and management 
Indicator 4.1 Attend early intervention service 
 
Formula 
Number of infants diagnosed with PCHI who attend early intervention services  








To be determined. 
Numerator data 
source:  
To be determined. 
Numerator data 
elements: 
Selection data elements: 
Date of birth 
Date audiological assessment completed 
Outcome of audiological assessment 
Date of first attendance early intervention service 




• Count is of all infants born in the designated calendar year where audiological assessment 
outcome is positive and date first attended Early Intervention Service is NOT NULL. 
• Time (days) elapsed from completion of screening test to commencement of audiological 
assessment calculated as the difference in days between Date audiological assessment 
completed and Date of first attendance early intervention – disaggregated as <6 days, 6–10 




Number of infants born in a calendar year who are diagnosed with PCHI. 
Denominator data 
collection: 
To be determined. 
Denominator data 
source:  
To be determined. 
Denominator data 
elements: 
Selection data element: 
 Date of birth 
 Outcome of audiological assessment 




• Count is of all infants born in the designated calendar year where audiological assessment 
outcome is positive. 
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Indicator 4.2 Infants fitted with an assistive hearing device  
 
Formula 
Number of infants diagnosed with PCHI who are fitted with an assistive hearing device  




Numerator definition: Number of infants born in a calendar year who are diagnosed with PCHI and are fitted with an 
assistive hearing device. 
Numerator data 
collection: 






• To be created in collaboration with jurisdictional health department and Australian Hearing  
Numerator 
specifications: 





Number of infants born in a calendar year who are diagnosed with PCHI. 
Denominator data 
collection: 
To be determined. 
Denominator data 
source: 
To be determined. 
Denominator data 
elements: 
Selection data elements: 
 Date of birth 
 Audiological assessment outcome  
 Disaggregation data elements: 
 Jurisdiction 
 Date screen completed 
 First assistive hearing device type 
Denominator 
specifications 
• Count is of all infants born in the designated calendar year where audiological assessment 
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Appendix A Neonatal Hearing Screening 
Working Group membership  
Table A.1: NHSWG membership  
NHSWG member Organisation 
Ms Melinda Bromley (Chair) DOHA, Assistant Secretary Population Health Programs Branch 
Mr Alan Keith (Secretariat) DOHA, Population Health Programs Branch 
Ms Karen Granton (Secretariat) DOHA, Population Health Programs Branch 
Ms Renee Garuccio Northern Territory Department of Health and Families,Northern Territory Hearing Services 
Professor Greg Leigh Royal Institute for Deaf and Blind Children / Australasian Newborn Hearing Screening 
Committee 
Ms Elizabeth Low DOHA, Office of Hearing Services 
Ms Jan MacLean West Australian Newborn Hearing Screening Program / Australasian Newborn Hearing 
Screening Committee 
Ms Tina Carter Consumer representative, Australia and New Zealand Parents of Deaf Children 
Ms Christine Sturrock AIHW, Cancer and Screening Unit 
Professor Melissa Wake Centre for Community and Child Health / Australasian Newborn Hearing Screening 
Committee 
Ms Alison King Australian Hearing, Principal Audiologist Paediatric Services  
Ms Jane McEntee Ministry of Health New Zealand, Antenatal and Newborn Screening Health and Disability  
Dr Elisabeth Murphy NSW Department of Health / Child Health and Wellbeing Subcommittee 
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Appendix B Neonatal Data
 Specification Subgroup 
membership 
Table B.1: NDSS membership 
NDSS member Organisation 
Christine Sturrock (Chair) AIHW, Cancer and Screening Unit 
Melissa Goodwin AIHW, Cancer and Screening Unit 
Theresa Negrello  AIHW, Cancer and Screening Unit 
Alan Keith DOHA, Population Health Programs Branch 
Alison King Australian Hearing, Principal Audiologist Paediatric Services 
Michelle Forte South Australian Department of Health, Newborn and Children’s Hearing Services 
Paula Laws AIHW, National Perinatal Statistics Unit (Collaborating Unit) 
Elizabeth Sullivan AIHW, National Perinatal Statistics Unit (Collaborating Unit) 
Lisa Hilder AIHW, National Perinatal Statistics Unit (Collaborating Unit) 
Shirley Glennon Queensland Health, Healthy Hearing Program 
Sue Stratton NSW Health, Hearing Health Network Co-ordinator 
Carol McWeeney New South Wales State wide Infant Screening Hearing Program 
Zeffie Poulakis The Royal Children’s Hospital, Melbourne, Victorian Infant Hearing Screening Program 
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Appendix C National Framework targets and indicator decision 
matrix 
Each of the 29 objectives, 69 standards and 83 targets of the Draft National Framework (later titled the National Framework for Neonatal 
Hearing Screening, NHSWG 2013) were systematically audited to assess their appropriateness for national reporting. Consideration was 
given to the fewest number of indicators which would appropriately measure performance of neonatal hearing screening in Australia. The 
aim was to create a set of indicators that were robust enough to measure performance of neonatal hearing screening at the national level, 
while providing minimal reporting burden to allow jurisdictions to better use resources in program management. Monitoring national 
performance indicators has to be less detailed than at a jurisdictional or service level and Table C.1 reflects this principle. The objectives, 
standards, and targets of the Draft National framework provide an appropriate model for quality service provision. 
Table C.1: Neonatal hearing screening: target performance indicator decision matrix.  
Note: that sections 3 Parental Support, 6 Coordination, Monitoring and Evaluation, and 7 Professional Education are not included as they refer to qualitative standards not appropriate for national reporting. 
Draft national framework objective Draft national framework targets 
Suitable for 
measuring 
performance at a 





1.1 To enable early identification of all babies 
with a congenital hearing loss of >40dB 
HL, including: bilateral, unilateral, sensory 
or neural hearing loss (e.g. Auditory 
Neuropathy Spectrum Disorder) and 
permanent conductive hearing loss. 
 
100% of eligible babies are offered hearing 
screening. 
 
No Although recognised as an important target 
that should be monitored, this can be provided 
at a jurisdictional level. 
- 
>97% of eligible babies complete a hearing 
screen. 
No Although recognised as important target that 
should be monitored nationally, this target is 
covered under the first target in 2.2. 
- 
100% babies not screened prior to hospital 
discharge are followed up within one month. 
No Although recognised as an important target 
that should be monitored, this can be provided 
at a jurisdictional level. 
For the purposes of national reporting, these 
data are sufficiently captured by indicator 1.1.  
- 
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Draft national framework objective Draft national framework targets 
Suitable for 
measuring 
performance at a 




1.2 To ensure that all parents are aware of 
newborn hearing screening and its 
benefits and risks. 
 
 
Written information that describes the screening 
process and the reason for screening is provided 
to parents. 
No Qualitative target that can be demonstrated 
and monitored by the jurisdictional programs. 
- 
2 Screening  
2.1 Parents are able to make an informed 
decision on hearing screening and 
diagnostic services. 
 
Written parental consent is obtained to perform a 
screen. 
No  Qualitative target that can be demonstrated 
and monitored by the jurisdictions programs. 
- 
<1% of parents decline screening. No  Although recognised as an important target 
that should be monitored, this can be provided 
at a jurisdictional level. 
These national performance indicators were 
created on the assumption that decline of 
service is a jurisdictional issue.  
- 
A decline form is signed by all parents who 
choose to decline a screen. 
No Qualitative target that can be demonstrated 
and monitored by the jurisdictional programs. 
- 
A decline to participate in screening is recorded 
appropriately in the infant’s medical file. 
No Qualitative target that can be demonstrated 
and monitored by the jurisdictional programs. 
 
Written consent is obtained to collect data for 
those babies with a refer (positive) result on the 
screen. 
No Not necessary to be monitored at a national 
level but a national data collection may only 
receive information on those infants for whom 
consent is obtained. 
- 
2.2 All eligible newborns complete a hearing 
screen. 
>97% eligible babies complete a hearing screen 
before one month corrected age. 
Yes Recognised as an important target that should 
be monitored nationally. 
1.1 
All babies with a ‘refer’ (positive) result are 
referred for audiological assessment. 
No Although recognised as an important target 
that should be monitored nationally, this target 
is included in objective 4.1 and will be 
monitored using the target >97% of infants 
with a positive screen commenced 
audiological assessment by three months 
corrected age. 
- 
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Draft national framework objective Draft national framework targets 
Suitable for 
measuring 
performance at a 




2.3 All babies in Neonatal Intensive Care 
Units (NICU) and Special Care Units are 
screened with technology capable of 
identifying Auditory Neuropathy Spectrum 
Disorder. 
All babies admitted to NICU are screened 
according to NICU protocols. 
No This is a standard of care and not appropriate 
for inclusion in national reporting against 
performance. 
- 
2.4 Results of screening processes are 
communicated to families accurately, 
effectively and considerately. 
All results are provided verbally and in written 
form. Outcomes are recorded. 
No Qualitative target that can be demonstrated 
and monitored by the jurisdictional programs. 
- 
2.5 Informed consent processes are followed 
for referral to diagnostic audiology. 
>99% parents of babies with a refer result 
consent to diagnostic assessment. 
No Recognised as an important target that should 
be monitored nationally. 
- 
2.6 To ensure newborns are referred in a 
timely manner. 
>97% babies with a refer (positive) result are 
referred, monitored and followed up through to 
diagnostic services. 
No  Although recognised as important target that 
should be monitored nationally, this TPI is a 
summary of the screening process and is 
covered in multiple subsequent indicators. 
- 
>97% of referrals to diagnostic assessment are 
made in less than 5 days. 
No Although recognised as an important target, 
this is covered in target 4.1.1. 
- 
2.7 To ensure that the number of infants 
referred for assessment and subsequently 
diagnosed with the target condition is 
appropriate for that population and is 
consistent with international standards. 
Approximately 0.1% of babies screened will be 
diagnosed with the target condition. 
Yes  Recognised as an important target that should 
be monitored nationally. 
 
3.2 
<4% of infants who are screened test positive for 
potential PCHI and are referred for audiological 
evaluation. 
Yes  Recognised as an important target that should 
be monitored nationally. 
2.1 
2.8 To provide parents with information 
explaining that changes can occur in their 
child’s hearing over time. 
All parents of babies screened are provided with 
a check list of developmental milestones for 
hearing and signs of hearing loss. 
No Qualitative target that can be demonstrated 
and monitored by the jurisdictional programs. 
- 
Parents with children at higher risk are provided 
with clear written information of their risk factors. 
No Qualitative target that can be demonstrated 
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Draft national framework objective Draft national framework targets 
Suitable for 
measuring 
performance at a 





4.1 To ensure that infants who meet the 
defined criteria for referral receive follow-
up audiological and medical evaluations in 
a timely manner. 
>97% of infants with a positive screen have 
commenced diagnostic assessment by three 
months corrected age. 
Yes  Recognised as an important target that should 
be monitored nationally. 
3.1 
>97% of families are referred to Australian 
Hearing within three days of confirmed hearing 
loss. 
No Qualitative target that can be demonstrated 
and monitored by the jurisdictional programs. 
- 
4.2 To define the degree, configuration and 
type of hearing loss in each ear for fitting 
of hearing devices. 
All children referred are tested with a full range of 
diagnostic electrophysiological tests in 
accordance with agreed national standards. 
No Qualitative target that can be demonstrated by 
audiologists and monitored by the 
jurisdictional programs. 
- 
Diagnostic electrophysiological tests and 
behavioural test outcomes are clearly and 
accurately documented. 
No Qualitative target that can be demonstrated by 
audiologists and monitored by the 
jurisdictional programs. 
- 
Results are included with referrals to Australian 
Hearing. 
No Qualitative target that can be demonstrated by 
audiologists and monitored by the 
jurisdictional programs. 
- 
Families are provided with an explanation of the 
results on completion of the diagnostic 
assessment. 
No Qualitative target that can be demonstrated by 
audiologists and monitored by the 
jurisdictional programs. 
- 
Families are provided with a written copy of the 
results within five working days. 
No Qualitative target that can be demonstrated by 
audiologists and monitored by the 
jurisdictional programs.  
- 
4.3 To ensure babies obtain otologic, 
ophthalmic and developmental 
assessment and the opportunity for 
aetiological investigation including genetic 
advice/counselling. 
An appointment with an otolaryngologist 
/paediatrician with expertise in paediatric hearing 
loss should be made within two weeks of 
confirmation of hearing loss. 
No  Standard of care that is not appropriate for 
national reporting. 
- 
Following confirmation of hearing loss, all babies 
are referred for otological and other appropriate 
medical evaluation so that a medical 
management plan including other interventions, 
can be developed by three months of age in 
collaboration with the family. 
No This is a standard of care and not a target for 
a national performance indicator. 
- 
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Draft national framework objective Draft national framework targets 
Suitable for 
measuring 
performance at a 




All families are provided with a written 
explanation of the implications of the outcomes of 
aetiological investigation. 
No Qualitative target that can be demonstrated 
and monitored by the jurisdictional programs. 
- 
There is evidence of processes for reviewing and 
correlating clinical, neurological, audiology (etc) 
findings for hearing loss that has been detected 
as a result of screening. 
No Qualitative target that can be demonstrated 
and monitored by the jurisdictional programs. 
- 
>97% of babies are seen within targeted 
timeframes. 
No  This target is a summary of other targets. - 
5 Early intervention and management  
5.1 Early intervention, support and advocacy 
services are family centred. 
>97% of families are provided with a range of 
options regarding amplification technology, 
communication and intervention within six weeks 
of diagnosis. 
No  Although important, it is suggested that this 
standard is best monitored at a jurisdictional 
level. 
- 
Families (particularly in rural and remote areas) 
are provided with information on eligibility and 
access to travel assistance particularly for rural 
and remote areas. 
No Qualitative target that can be demonstrated 
and monitored by Australian Hearing. 
- 
Services provide evidence of a mechanism to 
engage parents in the development of service 
delivery standards and protocols. 
No Qualitative target that can be demonstrated 
and monitored by Australian Hearing. 
- 
5.2 All families remain engaged with an early 
intervention service provider. 
Services demonstrate that protocols have been 
put in place to provide a smooth transition 
process between other hearing impairment 
services. 
No Qualitative target that can be demonstrated 
and monitored Australian Hearing. 
- 
Early intervention providers report on continuing 
enrolment or disengagement quarterly. 
No Qualitative target that can be demonstrated 
and monitored by Australian Hearing. 
- 
Families that disengage with an early intervention 
service provider are offered support through 
central family advocacy/support services to 
engage with alternative providers within two 
months. 
No Qualitative target that can be demonstrated 
and monitored by Australian Hearing. 
- 
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Draft national framework objective Draft national framework targets 
Suitable for 
measuring 
performance at a 




Service providers assist in the development of a 
transition plan six months prior to enrolment in an 
educational system. 
No Qualitative target that can be demonstrated 
and monitored by Australian Hearing. 
- 
5.3 All families are informed about the range 
and nature of early intervention service 
options in order to facilitate timely 
engagement with early intervention. 
Age of initiation of formal early intervention is 
recorded centrally in the program for all children 
diagnosed with permanent hearing impairment. 
Consider To be considered after initial implementation 
of the indicators. 
Would refer to 
4.2 
>97% of babies with permanent hearing 
impairment are engaged in formal early 
intervention by four months of corrected age. 
Consider To be considered after initial implementation 
of the indicators. 
Would refer to 
4.2 
Families who do not attend audiology or early 
intervention services are notified to the family’s 
GP and/or Maternity and Child Health Nurse for 
follow-up within four weeks. 
No Qualitative target that can be demonstrated 
and monitored by Australian Hearing. 
- 
5.4 All early intervention programs assess 
language skills, cognitive skills, auditory 
skills, speech, vocabulary, and social-
emotional development of all children with 
hearing impairment. 
Services demonstrate that all professional staff 
members have the skills/qualifications that are 
necessary for providing families with the highest 
quality of service specific to children with hearing 
impairment. 
No Qualitative target that can be demonstrated 
and monitored by Australian Hearing. 
- 
Services have a comprehensive orientation and 
training program for staff involved in the delivery 
of services to children and their families. 
No Qualitative target that can be demonstrated 
and monitored by Australian Hearing. 
- 
>97% of babies with confirmed hearing 
impairment receive a full developmental 
assessment with standardised assessment 
protocols (not criterion reference checklists) for 
language, speech, and nonverbal cognitive 
development by 12 months of age. 
No Beyond the scope of a national neonatal 
hearing screening program but could be 
monitored at a jurisdictional level. 
- 
>97% of babies with confirmed hearing 
impairment in early intervention programs receive 
a language, cognitive skills, auditory skills, 
speech, vocabulary, and social-emotional 
assessment at six-month intervals during the first 
three years of life. 
No Beyond the scope of a national neonatal 
hearing screening program but could be 
monitored at a jurisdictional level. 
- 
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Draft national framework objective Draft national framework targets 
Suitable for 
measuring 
performance at a 




5.5 Babies who have a permanent, moderate 
or greater bilateral sensorineural hearing 
loss are provided with 
amplification/implants in an appropriate 
time frame for optimal speech and 
language development. 
>97% babies diagnosed with a permanent 
hearing loss are referred to Australian Hearing. 
Yes Recognised as an important target that should 
be monitored nationally. 
3.1 
100% of referrals received by Australian Hearing 
are confirmed to the referral agency within 5 
days. 
Consider To be considered after initial implementation 
of the indicators. 
Would refer to 
4.1 
>97% of families attend appointment within three 
weeks of the referral. 
No Recognised as important but a jurisdictional 
matter. 
- 
Australian Hearing confirms attendance at initial 
appointment of all referred newborns. 
No Qualitative target that can be demonstrated 
and monitored by Australian Hearing and is 
therefore not necessary reporting at a national 
level. 
4.2 
>85% of children diagnosed with bilateral hearing 
loss >40 dBHL are fitted with amplification by six 
months of age. 
Yes Recognised as an important target that should 
be monitored nationally. 
4.2 
>95% of children diagnosed with a bilateral 
hearing loss >40 dBHL are fitted with 
amplification by 12 months of age. 
Yes Recognised as an important target that should 
be monitored nationally. 
4.2 
>97% of children with 3FAHL of ≥90 dBHL at the 
initial diagnostic audiology appointment are 
offered referral for cochlear implant candidacy. 
No Recognised as important but a jurisdictional 
matter. 
- 
Other children are offered a cochlear implant 
referral when appropriate to the family’s 
program.a 
No Qualitative target that can be demonstrated 
and monitored by Australian Hearing. 
- 
(a) Other reasons for referral include: parents’ wish to obtain information about cochlear implantation, child’s functional auditory performance is measured to fall > 2 standard deviations below average for the child’s age; 
aetiology of the hearing loss is one where research suggests that the child may benefit from a cochlear implant. 
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Appendix D Data elements required to calculate performance 
indicators  
METeOR and metadata 
METeOR stands for Metadata Online Repository and is Australia's repository for national metadata standards for the health, community 
services and housing assistance sectors developed by the Australian Institute of Health and Welfare. 
Metadata is often called ‘data about data’. More precisely, it is the underlying definition or structured description of the content, quality, 
condition or other characteristics of data. Metadata that have been endorsed for use across Australia are referred to as data standards.  
Below is a table that contains proposed data elements, their definitions and provides metadata information already held in METeOR if it 
exists. Where a data element needs to be developed, this is indicated in the table.  
Items with a  denote a data element that can be used as a statistical linkage key. These items can be calculated and added as a variable to 
the dataset before sharing this data set. This allows the removal of identifying information and thus protects privacy while enabling linkage 
with other data sets. 
Table D.1: Proposed data elements, definitions and metadata information held in METeOR for a national neonatal hearing screening data set  
 





Person information      
 Infant’s person ID Person identifier unique within an establishment or agency and jurisdiction. This is allocated at first 
contact with the service. An ID that is not duplicated in different jurisdictions is advisable for ease of 
national reporting.  
To be developed Data 
element 
. . 
 Infant’s given name The person’s identifying name within the family group or by which the person is socially identified, as 
represented by text. 
Person (name)—given 




 Infant’s family name That part of a name a person usually has in common with some other members of his/her family, as 
distinguished from his/her given names, as represented by text. 
Person (name)—family 




 Sex The biological distinction between male and female, as represented by a code. Person—sex, code N Data 
element 
287316 
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Demographic information     
 Geographic identifier of 
usual residence  
Geographical location of usual residence of the person, as represented by a code.  
Note: Geographical location is reported using Statistical Local Area (SLA) to enable accurate 
aggregation of information to larger areas within the Australian Standard Geographical Classification 
(ASGC) (such as Statistical Subdivisions and Statistical Divisions) as well as detailed analysis at the 
SLA level. 
Person—area of usual 
residence, geographical 





 Indigenous status Whether a person identifies as being of Aboriginal or Torres Strait Islander origin, as represented by 
a code. This is in accord with the first two of three components of the Commonwealth definition. 
Person—Indigenous 




 Culturally and 
linguistically diverse 
(CALD) identifier  
Includes those whose first language is one other than English, or whose family background involves 
migration from a non-English speaking country – as defined in 2006 census. 
To be developed Data 
element 
 
Birth information     





 Jurisdiction of birth The state or territory in which the baby was delivered, as represented by a code. Birth event—state/territory 




 Gestational age The age of a product of conception in completed weeks. Product of conception—





Screening information     
 Infant’s jurisdictional ID Person identifier unique within a jurisdictional screening program. This is allocated with the first 
contact with the service.  
To be developed Data 
element 
. . 
 Date screen completed Date on which infant received either a positive – and was therefore referred to audiological 
assessment – or negative screen result. 
To be developed Data 
element 
. . 
 Screen outcome Dichotomous data element indicating whether an infant tested positive or negative for potential PCHI. To be developed Data 
element 
. . 
Audiological assessment information 
 Date audiological 
assessment completed 





Outcome of audiological assessment including whether an infant was diagnosed with PCHI. To be developed Data 
element 
. . 
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 Type and degree of 
hearing loss 
A categorical data element that identifies the type and degree of hearing loss. To be developed  Data 
element 
. . 
Early intervention information 
 Date of first attendance 
early intervention 
Date on which an infant attends their first appointment at an early intervention service. To be developed Data 
element 
. . 
 Assistive hearing 
device flag 
Dichotomous data element that records whether it was decided to fit the infant with an assistive 
hearing device . 
To be developed Data 
element 
. . 
 Date first assistive 
hearing device fitted 
Date on which an infant receives their first fitting of a hearing device. To be developed Data 
element 
. . 
 First assistive hearing 
device type 
Categorical data element that records the type of first assistive hearing device fitted. To be developed Data 
element 
. . 
Note:  denotes statistical linkage key data item.
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Glossary 
This section provides a general description of the terms used in this working paper. The terms 
have been defined in the context of this paper; some terms may have other meanings in other 
contexts. 
 
Aboriginal and Torres Strait Islander: a person of Aboriginal and/or Torres Strait 
Islander descent who identifies as an Aboriginal and/or Torres Strait Islander. 
Asymptomatic: without symptoms. 
Auditory Brainstem Response Test (ABR): the ABR is an electrophysiological test that 
measures electrical activity generated in various parts of the nerve pathway from the ear 
to the brain when a sound is presented. Electrodes (small metal disks) are attached to the 
child's head and sounds are presented to the child’s ears through ear plugs or 
earphones.  
Audiologist: an audiologist is a university-trained professional who is specially 
qualified to measure hearing, diagnose the degree, configuration and type of hearing 
loss, advise on the non-medical management of hearing disorders, and supply and fit 
hearing aids and other hearing devices to suit. 
Audiology: a field of research and clinical practice devoted to the study of hearing 
disorders, assessment of hearing, hearing conservation, and aural rehabilitation. 
Automated Auditory Brainstem Response (AABR): a non-invasive screening ABR test 
that is used to identify whether a child is at risk for having a hearing loss. 
Baby referred directly to audiology: babies referred directly to audiological assessment 
because of identified risk factors. 
Bilateral hearing loss: a hearing impairment in both ears. 
Chronological age: is number of days since birth.  
Cochlear implant: unlike hearing aids, which simply amplify sound, a cochlear implant 
is a surgically implanted device that bypasses the part of the ear that is not working and 
electrically stimulates the hearing nerve directly. 
Corrected age: the age an infant would be had they been born on their due date. 
Corrected age takes into account the time between premature birth and the actual due 
date of a full term pregnancy. Calculating corrected age provides a truer reflection of 
what an infant’s developmental progress should be. Corrected age is calculated as 
chronological age less gestational age. 
Decibel (dB): the unit of measurement for the loudness of a sound. The higher the 
decibel level, the louder the sound. 
Diagnostic Audiology Assessment: an assessment that occurs after a child has received 
a ‘refer’ result in a second hearing screen. The assessment is performed by an 
audiologist, and includes diagnostic hearing tests to assess the type and degree of 
hearing impairment. 
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Early intervention programs: programs which aim to provide hearing impaired 
children in the first six months of life with immediate intervention. Children who 
undergo early intervention have significantly better outcomes than later-identified 
children in both speech and social-emotional development. 
False positive: a test result that incorrectly indicates a person may have the condition 
being tested. 
Gestational age: the duration of pregnancy in completed weeks calculated from the date 
of the first day of a woman’s last menstrual period and her baby’s date of birth, or via 
ultrasound, or derived from clinical assessment during pregnancy or from examination 
of the baby after birth. Gestational age is used to identify preterm births. 
Hearing aid: an electronic device that amplifies sound and conducts it to the ear. 
Hearing and communication improvement program: a habilitation or rehabilitation 
program that aims to ensure, over time, that the negative effects of the child’s hearing 
loss are minimised. A program would include assessment of the child’s hearing status, 
establishment of communication goals with the family, implementation of strategies to 
address the goals and evaluation of outcomes. The strategies usually, but not always, 
include the fitting of a hearing aid or other assistive device. 
Hearing Screening: hearing screening aims to identify children who are at risk for a 
hearing loss, so that they can be referred for further detailed assessment. A screening 
test result can be a pass (hearing is at levels required for normal speech and language 
development at the time of screen) or refer (at risk for hearing loss and requiring further 
assessment). Infants in Australia have their hearing screened with either AABR or OAE 
tests.  
Incidence: the number of new cases (for example, of an illness for event) occurring 
during a given period.  
Indigenous Australian: a person of Aboriginal and/or Torres Strait Islander descent 
who identifies as Aboriginal and/or Torres Strait Islander. 
Infant: the term infant is used to describe neonates, infants and children as they progress 
through the screening pathway. 
Jurisdiction of birth: the state or territory in which the baby was delivered. 
Jurisdiction of (the mother’s) residence at birth: geographical location of usual 
residence of the mother at the time she gave birth.  
Negative screen result: indicates that the screening test was negative for suspected 
hearing loss. 
Otoacoustic Emissions (OAE) Test: the OAE test measures the response of the outer 
hair cells in the inner ear (cochlea) to sound. A small probe is placed in the ear canal. A 
series of clicks or tones is presented to the child’s ear and a small microphone records 
echoes (emissions) that come from the cochlear. 
Positive predictive value of the screening test: the proportion of infants who test 
positive on their screening test for potential PCHI and upon further assessment receive a 
definitive diagnosis of PCHI. 
Positive screen: indicates that the screening test was positive for suspected hearing loss. 
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Positivity rate: the proportion of infants who are screened and test positive for potential 
PCHI. 
Preterm birth: an infant born where gestational age < 37 weeks. 
Program population: all live births in Australia  
Risk factor: an attribute or exposure that is associated with an increased probability of a 
specified outcome, such as occurrence of a disease. Risk factors are not necessarily the 
causes of disease. 
Screening: the performance of tests on apparently well people in order to detect a 
medical condition at an earlier stage than would otherwise be the case. Because a 
screening test is not intended to be diagnostic, a person with a positive or suspicious 
result must be referred for diagnosis and treatment.  
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National performance indicators 
for neonatal hearing screening 
in Australia
around half the children born with hearing impairment 
have no identified risk factor for the condition. it is 
widely acknowledged that delays in the identification 
and treatment of permanent childhood hearing 
impairment may profoundly affect quality of life in 
terms of language acquisition, social and emotional 
development, and education and employment 
prospects. all states and territories in australia have 
universal neonatal hearing screening. 
this working paper presents a set of performance 
indicators for monitoring neonatal hearing screening 
activity in australia at a national level. national 
evaluation and monitoring provides a measure of how 
well neonatal hearing screening is achieving its aims and 
objectives and will enable strengthening of screening 
practices and administrative processes to further 
improve outcomes for australian infants.
